[Federal Register Volume 79, Number 240 (Monday, December 15, 2014)]
[Notices]
[Pages 74097-74098]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-29289]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30-Day 15-14AUI]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to <a href="/cdn-cgi/l/email-protection#3956545b795a5d5a175e564f"><span class="__cf_email__" data-cfemail="a5cac8c7e5c6c1c68bc2cad3">[email protected]</span></a>. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

Proposed Project

    WISEWOMAN National Program Evaluation--New--National Center for 
Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for 
Disease Control and Prevention (CDC).

Background and Brief Description

    The CDC has supported the WISEWOMAN program (Well-Integrated 
Screening and Evaluation for Women Across the Nation) since 1995. The 
WISEWOMAN program is designed to serve low-income women ages 40-64 who 
have elevated risk factors for cardiovascular disease (CVD) and have no 
health insurance, or are underinsured for medical and preventive care 
services. Through the WISEWOMAN program, women have access to screening 
services for selected CVD risk factors such as elevated blood 
cholesterol, hypertension, and abnormal blood glucose levels; referrals 
to lifestyle programs; and referrals to medical care. WISEWOMAN 
participants must be co-enrolled in the CDC-sponsored National Breast 
and Cervical Cancer Early Detection Program (NBCCEDP).
    The WISEWOMAN program is administered through cooperative 
agreements with state, territorial, or tribal health departments. At 
present, approximately two-thirds of program funding is provided by CDC 
with the other one-third supplied by the state, territory, or tribal 
organization. Each WISEWOMAN awardee submits to CDC an annual progress 
report that describes program objectives and activities, and semi-
annual data reports (known as minimum data elements, or MDE) on the 
screening, assessment, and lifestyle program services offered to women 
who participate in the program (see WISEWOMAN Reporting System, OMB No. 
0920-0612, exp. 12/31/2016). Participant-level MDE are de-identified 
prior to transmission to CDC.
    In 2013, CDC released the fourth funding opportunity announcement 
(FOA) for the WISEWOMAN program (DP13-1302), which resulted in four-
year cooperative agreements with 22 state, territorial, and tribal 
health departments, including 5 new and 17 continuing awardees from the 
previous FOA. Key program elements were retained (e.g., provision of 
screening services, promotion of healthy lifestyle behaviors, and 
linkage to community resources), but a number of changes were 
incorporated into the program at that time due to shifts in 
populations, systems, and community needs. The current FOA reflects 
increased emphasis on improving access to clinical systems of care and 
increased emphasis on leveraging existing resources in the community. 
Lifestyle interventions have also been reframed to include lifestyle 
programs and health coaching sessions, and MDE have been updated to 
capture information about risk reduction counseling and participants' 
readiness to change. The current cooperative agreement also stresses 
monitoring and performance evaluation as key program dimensions. 
Additionally, more information is needed to augment that from previous 
evaluation efforts.
    CDC seeks to conduct a one-time, multi-component evaluation to 
assess the effectiveness of the program on individual-, organizational-
, and community-level outcomes. The in-depth assessment is designed to 
complement the routine progress and MDE information already being 
collected from WISEWOMAN program awardees. The new data collection will 
focus on obtaining qualitative and

[[Page 74098]]

quantitative information at the organizational and community levels 
about process and procedures implemented, and barriers, facilitators, 
and other contextual factors that affect program implementation and 
participant outcomes. Data collection activities will include a Program 
Survey with all WISEWOMAN awardee programs, administered in the second 
and fourth program years; a Network Survey of WISEWOMAN awardees and 
partner organizations, also conducted in the second and fourth program 
years; and a one-time Site Visit to a subset of awardees across the 
second to fourth program years. During site visits, semi-structured 
discussions will be conducted with WISEWOMAN staff and partner members 
who serve in diverse roles and are positioned to provide a variety of 
perspectives on program implementation.
    OMB approval is requested for three years. Participation is 
voluntary and there are no costs to respondents other than their time. 
The total estimated annualized burden hours are 132.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of      Avg. burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent        (in hr)
----------------------------------------------------------------------------------------------------------------
WISEWOMAN Awardee Administrators......  Program Survey..........              15               1               1
                                        Network Survey..........              15               1           30/60
                                        Site Visit Discussion                  6               1           75/60
                                         Guide.
Awardee Partners......................  Network Survey..........             147               1           30/60
                                        Site Visit Discussion                 12               1           45/60
                                         Guide.
Healthy Behavior Support staff........  Site Visit Discussion                 12               1           45/60
                                         Guide.
Clinical Providers....................  Site Visit Discussion                 12               1           45/60
                                         Guide.
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-29289 Filed 12-12-14; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>